Literature DB >> 30659272

High-content, cell-by-cell assessment of HER2 overexpression and amplification: a tool for intratumoral heterogeneity detection in breast cancer.

Huu Tuan Nguyen1, Daniel Migliozzi1, Bettina Bisig2, Laurence de Leval2, Martin A M Gijs3.   

Abstract

Immunohistochemistry and fluorescence in situ hybridization are the two standard methods for human epidermal growth factor receptor 2 (HER2) assessment. However, they have severe limitations to assess quantitatively intratumoral heterogeneity (ITH) when multiple subclones of tumor cells co-exist. We develop here a high-content, quantitative analysis of breast cancer tissues based on microfluidic experimentation and image processing, to characterize both HER2 protein overexpression and HER2 gene amplification at the cellular level. The technique consists of performing sequential steps on the same tissue slide: an immunofluorescence (IF) assay using a microfluidic protocol, an elution step for removing the IF staining agents, a standard FISH staining protocol, followed by automated quantitative cell-by-cell image processing. Moreover, ITH is accurately detected in both cluster and mosaic form using an analysis of spatial association and a mathematical model that allows discriminating true heterogeneity from artifacts due to the use of thin tissue sections. This study paves the way to evaluate ITH with high accuracy and content while requiring standard staining methods.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30659272      PMCID: PMC6522386          DOI: 10.1038/s41374-018-0172-y

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  23 in total

1.  FISH and chips: automation of fluorescent dot counting in interphase cell nuclei.

Authors:  H Netten; I T Young; L J van Vliet; H J Tanke; H Vroljik; W C Sloos
Journal:  Cytometry       Date:  1997-05-01

2.  Microfluidics-assisted fluorescence in situ hybridization for advantageous human epidermal growth factor receptor 2 assessment in breast cancer.

Authors:  Huu Tuan Nguyen; Raphaël Trouillon; Seiya Matsuoka; Maryse Fiche; Laurence de Leval; Bettina Bisig; Martin Am Gijs
Journal:  Lab Invest       Date:  2016-11-28       Impact factor: 5.662

3.  Immunohistochemistry as an important tool in biomarkers detection and clinical practice.

Authors:  Leandro Luongo de Matos; Damila Cristina Trufelli; Maria Graciela Luongo de Matos; Maria Aparecida da Silva Pinhal
Journal:  Biomark Insights       Date:  2010-02-09

Review 4.  Cancer heterogeneity: implications for targeted therapeutics.

Authors:  R Fisher; L Pusztai; C Swanton
Journal:  Br J Cancer       Date:  2013-01-08       Impact factor: 7.640

5.  Fully automated fluorescent in situ hybridization (FISH) staining and digital analysis of HER2 in breast cancer: a validation study.

Authors:  Elise M J van der Logt; Deborah A J Kuperus; Jan W van Setten; Marius C van den Heuvel; James E Boers; Ed Schuuring; Robby E Kibbelaar
Journal:  PLoS One       Date:  2015-04-06       Impact factor: 3.240

6.  Continuous quantification of HER2 expression by microfluidic precision immunofluorescence estimates HER2 gene amplification in breast cancer.

Authors:  Diego G Dupouy; Ata Tuna Ciftlik; Maryse Fiche; Déborah Heintze; Bettina Bisig; Laurence de Leval; Martin A M Gijs
Journal:  Sci Rep       Date:  2016-02-09       Impact factor: 4.379

7.  Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.

Authors:  Antonio C Wolff; M Elizabeth H Hammond; David G Hicks; Mitch Dowsett; Lisa M McShane; Kimberly H Allison; Donald C Allred; John M S Bartlett; Michael Bilous; Patrick Fitzgibbons; Wedad Hanna; Robert B Jenkins; Pamela B Mangu; Soonmyung Paik; Edith A Perez; Michael F Press; Patricia A Spears; Gail H Vance; Giuseppe Viale; Daniel F Hayes
Journal:  J Clin Oncol       Date:  2013-10-07       Impact factor: 44.544

Review 8.  HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneity.

Authors:  Wedad M Hanna; Josef Rüschoff; Michael Bilous; Renata A Coudry; Mitch Dowsett; Robert Y Osamura; Frédérique Penault-Llorca; Marc van de Vijver; Giuseppe Viale
Journal:  Mod Pathol       Date:  2013-06-28       Impact factor: 7.842

9.  Validation of a new classifier for the automated analysis of the human epidermal growth factor receptor 2 (HER2) gene amplification in breast cancer specimens.

Authors:  Daniela Furrer; Simon Jacob; Chantal Caron; François Sanschagrin; Louise Provencher; Caroline Diorio
Journal:  Diagn Pathol       Date:  2013-02-04       Impact factor: 2.644

10.  Comparison of automated and manual FISH for evaluation of HER2 gene status on breast carcinoma core biopsies.

Authors:  Christian Ohlschlegel; Doris Kradolfer; Margreth Hell; Wolfram Jochum
Journal:  BMC Clin Pathol       Date:  2013-04-20
View more
  1 in total

Review 1.  FISH and chips: a review of microfluidic platforms for FISH analysis.

Authors:  Pablo Rodriguez-Mateos; Nuno Filipe Azevedo; Carina Almeida; Nicole Pamme
Journal:  Med Microbiol Immunol       Date:  2020-01-21       Impact factor: 3.402

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.